{"title":"[GLYCEMIC CONTROL IN DIABETES MELLITUS PATIENTS WITH CHRONIC KIDNEY\nDISEASE – HOW TO CHOOSE HYPOGLYCEMIC AGENT]?","authors":"M Baretić, V Bralić Lang","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The management of hyperglycemia in patients with chronic kidney disease (CKD) is complex, and the goals and methods\nregarding glycemic control are not clearly defined. Although aggressive glycemic control seems to be advantageous in\nearly diabetic nephropathy, outcome data supporting tight glycemic control in patients with advanced CKD are lacking.\nChallenges in the management of such patients include monitoring difficulties and the complexity of available treatments.\nIn this article, we review the current treatment options for patients with diabetes and CKD discussing all hypoglycemic\nagents that currently are available, as well as insulin, along with their indications and contraindications. The aim is to\nprovide useful information to family physicians when deciding on individualized glycemic goals and appropriate therapy\nfor patients with early or end stages of CKD.</p>","PeriodicalId":35756,"journal":{"name":"Acta Medica Croatica","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2016-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Medica Croatica","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
The management of hyperglycemia in patients with chronic kidney disease (CKD) is complex, and the goals and methods
regarding glycemic control are not clearly defined. Although aggressive glycemic control seems to be advantageous in
early diabetic nephropathy, outcome data supporting tight glycemic control in patients with advanced CKD are lacking.
Challenges in the management of such patients include monitoring difficulties and the complexity of available treatments.
In this article, we review the current treatment options for patients with diabetes and CKD discussing all hypoglycemic
agents that currently are available, as well as insulin, along with their indications and contraindications. The aim is to
provide useful information to family physicians when deciding on individualized glycemic goals and appropriate therapy
for patients with early or end stages of CKD.
期刊介绍：
ACTA MEDICA CROATICA publishes original contributions to medical sciences, that have not been previously published. All manuscripts should be written in English.
分享
京公网安备 11010802042870号
京ICP备2023020795号-1
求助内容：
应助结果提醒方式：
扫码关注我们
